Efficacy of mako,marznjosh,baboona,qaisoom in vaginal discharge
Phase 2
- Conditions
- Health Condition 1: N760- Acute vaginitis
- Registration Number
- CTRI/2024/05/067720
- Lead Sponsor
- Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married females in the reproductive age group (18 to 49 years)
Subjects presenting with white discharge Per vaginum
Subjects presenting with chronic cervicitis and erosion
Exclusion Criteria
Pregnant females
Patient presenting with discharge due to sexually transmitted infections and pelvic inflammatory disease
Patient with systemic diseases like Diabetes mellitus Malignancy etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in vaginal pHTimepoint: After every 15 days during trial to record vaginal pH drug compliance and any adverse effects. <br/ ><br>Once post-trial after menstruation <br/ ><br>
- Secondary Outcome Measures
Name Time Method Improvement in vulvo vaginal symptoms like discharge <br/ ><br>Improvement in Quality of life <br/ ><br>Timepoint: After every 15 days during trial to record vaginal pH drug compliance and any adverse effects. <br/ ><br>Once post-trial after menstruation <br/ ><br>